IQ Capital

Activity from announced rounds

All recorded activity
Rounds participated in
9
Confirmed lead rounds
1
7 roles undisclosed
New companies
9
First participation on record · 0 follow-on
Funding in participating rounds
$283.9M
9 disclosed · full round size, not this investor’s share

By stage

Series A4
Seed2
Undisclosed2
Series C+1

By primary sector

Biotech3
Climate tech2
Cybersecurity2
Hardware1
Industrial tech1

By country

United Kingdom8
Germany1

Rounds

9 in all activity
Undecimal Bio

Undecimal Bio develops delivery molecules that help RNA medicines reach specific tissues, with initial research programmes in kidney and vascular disease.

$18MSeed
Lead
Mindgard

Mindgard helps enterprise security teams find and address vulnerabilities in AI models, applications and agents.

$30MSeries A
Participant
QuantumDiamonds

Develops technology to test and find defects in semiconductor products

€15MUndisclosed
Role not disclosed
IMU Biosciences

Profiles human immune systems using multi-omic analysis and machine learning for disease research.

$53MSeries A
Role not disclosed
RevEng.AI

Provides binary-level AI analysis of compiled software to detect hidden vulnerabilities and supply chain threats

$15MSeries A
Role not disclosed
Imperagen

Uses quantum physics simulation and AI to engineer high-performance enzymes for pharma and industrial markets

£5MSeed
Role not disclosed
Nyobolt

Develops ultra-fast-charging battery systems for autonomous robots, physical AI applications, and AI data center power infrastructure

$60MSeries C
Role not disclosed
Rivan

Develops synthetic fuel infrastructure for domestic energy production

$34MUndisclosed
Role not disclosed
Isembard

Develops software to automate manufacturing of key component parts for industries

$50MSeries A
Role not disclosed